UCB Showcases Key Rheumatology Data at ACR Convergence 2021
Go back to UCB Showcases Key Rheumatology Data at ACR Convergence 2021| (NYSE: UCB) | Delayed: 35.29 +0.14 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.15 | 52 Week High | $ | |||
| Open | $35.58 | 52 Week Low | $ | |||
| Day High | $35.67 | P/E | N/A | |||
| Day Low | $34.91 | EPS | $ | |||
| Volume | 670,752 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 119.35 +2.28 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $117.07 | 52 Week High | $46.25 | |||
| Open | $121.61 | 52 Week Low | $32.74 | |||
| Day High | $121.61 | P/E | N/A | |||
| Day Low | $119.21 | EPS | $0.00 | |||
| Volume | 59,276 | |||||
